Vnitr Lek 2017, 63(7-8):518-526 | DOI: 10.36290/vnl.2017.106

Nosocomial pneumonia

Jana Skřičková
Klinika nemocí plicních a TBC LF MU a FN Brno, pracoviště Bohunice

Nosocomial pneumonia (hospital-acquired pneumonia - HAP) is the form of pneumonia the symptoms of which present after more than 2 days (> 48 hours) of admission to hospital or as late as 14 days of discharge from hospital. The HAP pneumonias represent 13-18 % of all nosocomial infections. Incidence of HAP is the most frequent in mechanically ventilated patients. The type and representation of HAP agents primarily depends on the length of a patient's stay in hospital and on their condition and character of treatment. Diagnosing of pneumonia is based on anamnesis, physical and X-ray findings, results of examination of microbiological samples from the respiratory tract, hemoculture, the pleural effusion test, serological, hematological and biochemical tests. Antibiotic treatment is key to the comprehensive treatment of HAP. The HAP treatment always requires the dosing of antibiotics near the upper limit of the possible range. A precondition for successful avoidance of HAP pneumonias is the creation of a preventive programme with active engagement of medical staff.

Keywords: diagnostics; HAP pneumonia; treatment; ventilator-associated pneumonia

Received: June 3, 2017; Accepted: June 20, 2017; Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skřičková J. Nosocomial pneumonia. Vnitr Lek. 2017;63(7-8):518-526. doi: 10.36290/vnl.2017.106.
Download citation

References

  1. Jarvis WR. Nosocomial pneumonia. Marcel Dekker: New York - Basel 2000. IBSN 978-0824799427. Go to original source...
  2. Cunha AB. Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia. Emedicine. Medscape Reference. Drugs &Diseases. 2017. Dostupné z WWW: <http://emedicine.medscape.com/article/234753-overview>.
  3. Votava M, Jindrák V. Epidemiologie a etiologie nozokomiální pneumonie. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.
  4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165(7): 867-903. Go to original source... Go to PubMed...
  5. Kollef MH, Morrow LE, Biederman MS et al. Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia. Chest 2006; 129(5): 1210-1218. Go to original source... Go to PubMed...
  6. Carrabba M., Zarantolello M, Bonara P et al. Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression. Eur Respir J 2012; 40(5): 1201-1210. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00187811>. Go to original source... Go to PubMed...
  7. Leroy O, Giradie P, Yaydapanah Y et al. Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens. Eur Respir J 2002; 20(2): 432-439. Go to original source... Go to PubMed...
  8. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest 2006; 130(2): 597-604. Go to original source... Go to PubMed...
  9. Kollef MH, Morow LE, Niederman MS et al. Clinical Characteristics and Treatment Pattnerns Among Patients With Ventilator-Associated Pneumonia. Chest 2006; 129(5): 1210-1218. Erratum in Chest 2006; 130(1): 308. Go to original source... Go to PubMed...
  10. Kornum JB, Norgaard M, Dethlefsen C et al. Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2010; 36(6): 1330-1336. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00184209>. Go to original source... Go to PubMed...
  11. Chytra I, Ševčík P, Zvoníček V. Patogeneze, patofyziologie a rizikové faktory nozokomiální pneumonie. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.
  12. Nseir R, Di Pompeo C, Jozefowicz E et al. Relationship between tracheostomy and ventilator-associated pneumonia: a case control study. Eur Respir J 2007; 30(2): 314-320. Go to original source... Go to PubMed...
  13. [American Thoracic Society; Infectious Disease Society of America]. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healtcare associated Pneumonia. Am J Respir Crit Care Med 2005; 171(4): 388-416. Go to original source... Go to PubMed...
  14. Skřičková J, Salajka F, Ševčík P. Anamnéza a fyzikální nález u zánětů plic. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.
  15. Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: International Guidelines or Management of Severe Sepsis and Septic Shock: 2008. Crit Care Med 2008; 36(1): 296-327. Erratum in Crit Care Med 2008; 36(4):1394-1396. Go to original source... Go to PubMed...
  16. Hausfater P, Garric S, Ben Ayed S et al. Usefulness of procalcitonin as a marker of Systemic infection in emergency department patients: a prospective study. CID 2002; 34(7): 895-901. Go to original source... Go to PubMed...
  17. Decramer M, Roussos C. Imaging in lung disease. Eur Respir J 2002; 19(Suppl 35): 1-2. Go to original source... Go to PubMed...
  18. Nebeský T. Zobrazovací metody v diagnostice pneumonií. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.
  19. Votava M, Jindrák V. Mikrobiologická diagnostika pneumonií a její interpretace. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.
  20. Skřičková J, Pavlík P. Odběry materiálnu na mikrobiologické vyšetření v diagnostice pneumonií. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.
  21. Bulpa PA, Dive AM, Mertens L et al. Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients. Eur Respir J 2003; 21(3): 489-494. Go to original source... Go to PubMed...
  22. Papaziann L, Gainnier M. Indications of BAL, lung biopsy or both in mechanically ventilated patients with unexplained infiltrations. Eur Respir J 2003; 21(3): 383-384. Go to original source... Go to PubMed...
  23. Jindrák V, Votava M. Úvodní antibiotická léčba zánětů plic - kritéria pro volbu antibiotika. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.
  24. Rello J, Ulldemolins M, Lisboa T et al. Determinations of prescription and choice of empirical therapie for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 2011; 37(6): 1332-1339. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00093010>. Go to original source... Go to PubMed...
  25. Jakubec P, Kolek V, Kolář M. Diagnostika a léčba těžké pneumonie. In: Kolek V et al. Doporučené postupy v pneumologii. 2nd ed. Maxdorf: Praha 2016. ISBN 978-80-7345-507-1.
  26. Aarts MA, Hancock JN, Heyland D at al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials. Crit Care Med 2008; 36(1): 108-117. Go to original source... Go to PubMed...
  27. Chytra I, Ševčík P, Votava M et al. Prevence nozokomiální pneumonie. In: Ševčík P, Skřičková J, Šrámek V et al. Záněty plic v intenzivní medicíně. Galén: Praha 2004. ISBN 80-7262-278-1.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.